Daniel J. Becker is Director at Pandion Therapeutics, Inc. (PAND). They have made 10 open-market trades across 4 companies since 2018, most recently 2025-05-21.
CIK 0001752139
9 open-market purchases totalling $46.4M since 2018, against 1 sale. Across 9 scored buys the stock is up 35.0% at ninety days, and 29.5 points ahead of the S&P over the same stretch.
9 scored purchases · one row per filing · discretionary only
| 7d | 30d | 90d | |
|---|---|---|---|
| Accuracy | 33% | 33% | 78% |
| Avg Move | -1.9% | +2.6% | +35.0% |
| Alpha | -3.0% | +0.3% | +29.5% |
| Scored | 9 | 9 | 9 |
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| SLRN | SELL | 2024-07-17 | 2024-07-19 | $6.86 | $7 | -7.1% | -32.4% | +0.3% |
| SLRN | BUY | 2023-05-09 | 2023-05-11 | $18.00 | $54K | -15.1% | -25.3% | +1.3% |
| DAWN | BUY | 2021-06-01 | 2021-06-01 | $16.00 | $80K | -3.8% | +6.9% | +26.5% |
| PAND | BUY | 2020-11-19 | 2020-11-23 | $15.12 | $6.0M | -7.5% | -13.8% | +42.2% |
| PAND | BUY | 2020-11-17 | 2020-11-19 | $15.31 | $867K | +4.4% | -6.8% | +35.4% |
| PAND | BUY | 2020-07-21 | 2020-07-21 | $18.00 | $13.0M | -6.7% | -2.2% | -38.8% |
| PRNB | BUY | 2019-11-20 | 2019-11-22 | $29.94 | $1.6M | +13.6% | +80.7% | +118.1% |
| PRNB | BUY | 2019-10-28 | 2019-10-30 | $33.48 | $5.2M | -8.4% | +3.2% | +47.5% |
| PRNB | BUY | 2019-10-18 | 2019-10-22 | $28.00 | $15.0M | +13.2% | -1.3% | +91.5% |
| PRNB | BUY | 2018-09-18 | 2018-09-20 | $17.00 | $4.6M | -6.7% | -17.9% | -8.5% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.